Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis.

Dohmen K, Onohara SY, Harada S

Open source

DOI
10.4166/kjg.2021.092
Published
2021 Oct 25
Container
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4166/kjg.2021.092,
  title = {Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis.},
  author = {Dohmen K and Onohara SY and Harada S},
  year = {2021},
  journal = {The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi},
  doi = {10.4166/kjg.2021.092},
  url = {https://doi.org/10.4166/kjg.2021.092}
}

RIS

TY  - JOUR
TI  - Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis.
AU  - Dohmen K
AU  - Onohara SY
AU  - Harada S
PY  - 2021
JO  - The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
DO  - 10.4166/kjg.2021.092
UR  - https://doi.org/10.4166/kjg.2021.092
ER  - 

APA

K, D., SY, O., & S, H. (2021). Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis.. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi. https://doi.org/10.4166/kjg.2021.092

Source records